Blood test for two proteins in knee osteoarthritis
Part of Bones, joints & muscles clinical trials.
This study looks at two substances in your blood that might be linked to knee osteoarthritis. It may help doctors better understand joint damage and could lead to better ways to track the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 40 and 75 years old.
- You must have a doctor's diagnosis of knee osteoarthritis.
- You must not have had any knee surgery or major knee injury.
- You must not have an inflammatory disease like rheumatoid arthritis.
- You must not have had a knee injection (such as cortisone or PRP) in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain enzymes in the blood of women with knee osteoarthritis. It may help doctors understand how arthritis works and could lead to better treatments.
This study looks at whether certain blood cell ratios can predict how well a knee osteoarthritis treatment called platelet-rich plasma (PRP) works. PRP is made from your own blood and injected into the knee to help reduce pain and improve function.
This study looks at how knee osteoarthritis or other types of knee arthritis progress over time, using blood tests and X-rays. It aims to find markers that could predict whether the disease will get worse, which may help guide treatment decisions.
This study looks at two substances in the blood (fetuin-A and COMP) to see if they are linked to knee osteoarthritis severity. Results may help understand the disease better.
This study looks at how knee osteoarthritis (a common condition where the cushioning in the knee joint wears down) affects physical function, even when people report similar levels of pain. It aims to understand why some people with the same pain might have more difficulty with daily activities, which could lead to better targeted treatments.
This trial tests an injection of your own blood cells to treat knee osteoarthritis pain. It aims to see if this injection can reduce pain and improve knee function better than standard care.
Hear when a new Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.